ResMed Inc (NYSE:RMD)
$ 234.42 1.84 (0.79%) Market Cap: 34.14 Bil Enterprise Value: 34.57 Bil PE Ratio: 30.81 PB Ratio: 6.57 GF Score: 99/100

Resmed Inc to Acquire Medifox Dan GmbH Call Transcript

Jun 14, 2022 / 03:00PM GMT
Release Date Price: $202.01 (-0.19%)
Operator

Hello, and welcome to the ResMed webcast conference call. My name is Kevin, and I'll be your operator for today's call. (Operator Instructions) Please note, this conference is being recorded. I will now turn the call over to Amy Wakeham, Vice President, Investor Relations and Corporate Communications. Amy, you may begin.

Amy Wakeham
ResMed Inc. - VP of IR & Corporate Communications

Great. Thank you, Kevin, and thank you all for joining us today to discuss this exciting announcement of ResMed's latest acquisition. By now, I expect you all have seen the press release we issued overnight announcing a signed, definitive agreement to acquire MEDIFOX DAN, a German leader in out-of-hospital solutions for providers in major settings across the care continuum.

The press release is posted on our website, as is the investor presentation, both of which were filed with the SEC via a Form 8-K earlier this morning. Today's call will focus on the announced acquisition. We will not be providing any financial or operational updates to the quarter. I do want to

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot